| Literature DB >> 35052609 |
Luigi Castaldo1, Luana Izzo1, Anna Gaspari1, Sonia Lombardi1, Yelko Rodríguez-Carrasco2, Alfonso Narváez1, Michela Grosso3, Alberto Ritieni4.
Abstract
Agro-industrial wastes contain a large number of important active compounds which can justify their use as innovative ingredients in nutraceutical products. This study aimed to provide a complete analysis of active molecules, namely (poly)phenols in pea pods water-based extracts, through a UHPLC-Q-Orbitrap HRMS methodology. Data showed that 5-caffeoylquinic acid, epicatechin, and hesperidin were the most relevant (poly)phenols found in the assayed extracts, with a mean value of 59.87, 29.46, and 19.94 mg/100 g, respectively. Furthermore, changes in antioxidant capacity and bioaccessibility of total phenolic compounds (TPC) after the simulated gastrointestinal (GI) process were performed using spectrophotometric assays (FRAP, DPPH, ABTS, and TPC by Folin-Ciocalteu). The acid-resistant capsules (ARC) and the non-acid resistant capsules (NARC) containing the pea pod extract underwent simulated GI digestion. The results suggested that the ARC formulations were able to preserve the active compounds along the simulated GI process, highlighting a higher TPC value and antioxidant capacity than the NARC formulations and the not-encapsulated extracts. Hence, the pea pods water-based extracts could be utilized as a potential alternative source of active compounds, and the use of ARC could represent a suitable nutraceutical formulation to vehiculate the active compounds, protecting the chemical and bioactive properties of (poly)phenols.Entities:
Keywords: bioaccessibility; bioactive compounds; food waste valorization; nutraceutical; pea; polyphenols
Year: 2021 PMID: 35052609 PMCID: PMC8772770 DOI: 10.3390/antiox11010105
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Phenolic acids and flavonoids content in the pea pods water-based extracts.
| Compounds | Averange (mg/100 g) | ±SD |
|---|---|---|
| PHENOLIC ACIDS | ||
| Cinnamic acid | ||
| Quinic acid | 7.20 | 0.91 |
| 5-caffeoylquinic acid | 59.87 | 0.73 |
| N.D. | ||
| Ferulic acid | N.D. | |
| Rosamarinic acid | 0.78 | 0.31 |
| SUM | 67.85 | 0.65 |
| Benzoic Acid | ||
| Gallic acid | 5.30 | 0.69 |
| Protocatechuic acid | N.D. | |
| SUM | 5.30 | 0.69 |
| FLAVONOIDS | ||
| Flavones | ||
| Luteolin | 0.42 | 0.12 |
| Apigenin-7- | N.D. | |
| Apigenin | 0.12 | 0.01 |
| Diosmin | <LOD | |
| Kaemferol 3-glucoside | 3.50 | 0.16 |
| SUM | 3.62 | 0.10 |
| Flavanols | ||
| Catechin | 16.87 | 0.10 |
| Epicatechin | 29.46 | 0.41 |
| SUM | 46.33 | 0.25 |
| Flavanones | ||
| Naringenin | 1.67 | 0.04 |
| Naringin | N.D. | |
| Hesperidin | 19.94 | 3.62 |
| SUM | 21.61 | 1.83 |
| Flavonols | ||
| Isorhamnetin 3-rutinoside | N.D. | |
| Quercetin | 2.70 | 0.09 |
| Quercetin 3-galattoside | 0.73 | 0.00 |
| Rutin | 14.63 | 1.47 |
| SUM | 18.06 | 0.52 |
| Isoflavone | ||
| Genistein | 7.41 | 0.05 |
| Myricetin | 8.59 | 0.09 |
| Daidzein | N.D. | |
| SUM | 16.00 | 0.07 |
| TOTAL (POLY)PHENOLS | 178.79 | 0.59 |
N.D., not detected.
Bioaccessibility of polyphenolic compounds in pea pods water-based extracts encapsulated in the NARC and ARC formulation.
| Samples | TPC mg GAE/g ± SD | |
|---|---|---|
| Pea pod extract | 8.22 ± 0.31 | |
| NARC | ARC | |
| Digestion Stage | ||
| Oral stage | N.D. | N.D. |
| Gastric stage | 1.12 ± 0.03 | N.D. |
| Duodenal stage | 1.84 ± 0.08 * | 2.01 ± 0.03 * |
| Pronase E | 1.95 ± 0.07 * | 3.39 ± 0.06 * |
| Viscozyme L | 1.78 ± 0.08 * | 2.08 ± 0.07 * |
| Total colonic stage | 3.73 ± 0.08 * | 5.47 ± 0.07 * |
Differences between groups were statistically analyzed with Tukey’s test; * p-value ≤ 0.05 was considered significant. Abbreviations: mg GAE/g: milligrams of gallic acid equivalent per gram of dry extract; N.D., not detected.
Antioxidant capacity of NARC and ARC formulations evaluated by FRAP, DPPH, and ABTS assays during simulated GI digestion.
| DPPH mmol/kg ± SD | ABTS mmol/kg ± SD | FRAP mmol/kg ± SD | ||||
|---|---|---|---|---|---|---|
| Not Digested | 13.7 ± 1.1 | 18.3 ± 1.2 | 12.3 ± 1.1 | |||
| NARC | ARC | NARC | ARC | NARC | ARC | |
| Digestion stage | ||||||
| Oral stage | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. |
| Gastric stage | 1.6 ± 0.1 | N.D. | 2.0 ± 0.3 | N.D. | 0.9 ± 0.1 | N.D. |
| Duodenal stage | 2.1 ± 0.5 | 2.6 ± 0.4 | 3.2 ± 0.2 | 4.0 ± 0.5 | 1.4 ± 0.1 * | 2.1 ± 0.2 * |
| Pronase E stage | 2.3 ± 0.3 * | 4.5 ± 0.5 * | 4.6 ± 0.4 * | 5.9 ± 0.5 * | 3.4 ± 0.3 * | 4.6 ± 0.4 * |
| Viscozyme L stage | 1.9 ± 0.2 | 2.1 ± 0.5 | 2.8 ± 0.3 * | 3.6 ± 0.5 * | 2.4 ± 0.2 * | 3.9 ± 0.3 * |
| Total colonic stage | 4.2 ± 0.3 * | 6.6 ± 0.5 * | 7.4 ± 0.4 * | 9.5 ± 0.5 * | 5.8 ± 0.3 * | 8.5 ± 0.4 * |
Differences between groups were statistically analyzed with Tukey’s test; * p-value ≤ 0.05 was considered significant. Abbreviations: N.D., not detected.